Literature DB >> 22491048

Corticosteroids in the treatment of chemotherapy-induced nausea and vomiting.

Sally Yowell Barbour1.   

Abstract

Chemotherapy-induced nausea and vomiting (CINV) is one of the most feared side effects of cancer treatment, despite the advances over the past decades. Corticosteroids have been shown to be effective in the management of CINV. These agents are usually used in combination with serotonin antagonists and neurokinin-1 antagonists for highly or moderately emetogenic chemotherapy or as monotherapy for low-emetogenic chemotherapy. Consensus guidelines provide guidance regarding the scenarios in which corticosteroids are recommended. This article reviews the mechanism of action, role, and safety of corticosteroids in the management of CINV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22491048     DOI: 10.6004/jnccn.2012.0049

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  7 in total

1.  Patterns of antiemetic prophylaxis for chemotherapy-induced nausea and vomiting in China.

Authors:  Xianglong Zong; Jie Zhang; Xin Ji; Jie Gao; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2016-04       Impact factor: 5.087

2.  Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis.

Authors:  Takamichi Yokoe; Tetsu Hayashida; Aiko Nagayama; Ayako Nakashoji; Hinako Maeda; Tomoko Seki; Maiko Takahashi; Toshimi Takano; Takayuki Abe; Yuko Kitagawa
Journal:  Oncologist       Date:  2018-10-17

Review 3.  Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations.

Authors:  Bernardo Leon Rapoport; Matti Aapro; Martin R Chasen; Karin Jordan; Rudolph M Navari; Ian Schnadig; Lee Schwartzberg
Journal:  Drug Des Devel Ther       Date:  2017-09-05       Impact factor: 4.162

4.  Avascular Necrosis of Bone following Chemotherapy in Cancer Patients with Coagulopathy: Report of Two Cases.

Authors:  Hui-Ching Hsu; Tzu-Yao Liao; Dave Wei-Chih Chen; Yu-Hsiang Juan; Chuang-Chi Liaw
Journal:  Case Rep Oncol       Date:  2018-03-27

Review 5.  Extended release granisetron: Review of pharmacologic considerations and clinical role in the perioperative setting.

Authors:  Anh L Ngo; Vwaire Orhurhu; Ivan Urits; Edwin O Delfin; Medha Sharma; Mark R Jones; Omar Viswanath; Richard D Urman
Journal:  Saudi J Anaesth       Date:  2019 Jul-Sep

6.  Knowledge, practice and perceived barriers towards chemotherapy induced nausea and vomiting in prophylaxis guideline adherence among nurses in oncology units at selected hospitals, in Addis Ababa, Ethiopia, a cross-sectional study.

Authors:  Deneke Gebre; Rajalakshmi Murugan; Ketema Bizuwork; Teshome Habte Wurjine
Journal:  BMC Nurs       Date:  2022-08-11

7.  Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic Chemotherapy.

Authors:  Zhihuang Hu; Wenhua Liang; Yunpeng Yang; Dorothy Keefe; Yuxiang Ma; Yuanyuan Zhao; Cong Xue; Yan Huang; Hongyun Zhao; Likun Chen; Alexandre Chan; Li Zhang
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.